logo

For the Inventor, By the Inventor

Al-Ahsa, Saudi Arabia

Anroop B Nair

This inventor holds 15 USPTO granted patents and 1 published patent application. Top assignee: King Faisal University. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anroop B Nair. Retrieved from https://idiyas.com/inventor/anroop-b-nair

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 100.0

Average Co-Inventor Count = 11.3

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Hofouf, SA (2022)
  • Al-Ahsa, SA (2023 - 2024)

Company Filing History:

goldMedal15 out of 820 
 
King Faisal University
 patents

Years Active: 2022-2025

Loading Chart...
15 patents (USPTO):Explore Patents
1. 12297204 - 5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agents (2025-05-13),
2. 12221450 - 5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agents (2025-02-11),
3. 12187733 - 5-(Substitutedphenyl)-7-Imino-7,8-Dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agents (2025-01-07),
4. 11974991 - Adenosine receptor activity of methyl/ethyl 3-(substituted benzoyl)-6,8-dimethylindolizine-2-substituted-1-carboxylates (2024-05-07),
5. 11964982 - 5-(3-substituted phenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agents (2024-04-23),
6. 11938120 - Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents (2024-03-26),
7. 11932649 - 5-(3-substituted phenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agents (2024-03-19),
8. 11926627 - Substituted 7-methyl quinoline derivatives as antitubercular agents (2024-03-12),
9. 11919900 - 1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents (2024-03-05),
10. 11884677 - 5-(substitutedphenyl)-7-imino-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agents (2024-01-30),
11. 11884631 - Substituted phenyl quinolin-l-ium bromide derivative as anti-tubercular agents (2024-01-30),
12. 11845746 - Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents (2023-12-19),
13. 11807640 - 7-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1,7-dicarboxylates as anti-tubercular agents (2023-11-07),
14. 11807553 - Decontamination of water using guar gum derivatives and applications thereof (2023-11-07),
15. 11530217 - Antitubercular compounds (2022-12-20),

Title: Anroop B Nair: Innovator in Antibacterial Compounds

Introduction

Anroop B Nair is a prominent inventor based in Al-Ahsa, Saudi Arabia. He has made significant contributions to the field of antibacterial agents, holding a total of 15 patents. His work focuses on developing compounds that target microbial and bacterial infections, showcasing his commitment to advancing healthcare solutions.

Latest Patents

Among his latest patents are innovative compounds identified as 5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues. These compounds are designed as antibacterial agents, specifically targeting microbial and bacterial infections. The formulations include various substituents that enhance their efficacy as anti-microbial or anti-bacterial agents.

Career Highlights

Anroop B Nair is affiliated with King Faisal University, where he continues to engage in research and development of novel antibacterial compounds. His academic and professional journey reflects a dedication to innovation in the pharmaceutical field.

Collaborations

Anroop has collaborated with notable colleagues, including Mahesh Attimarad and Katharigatta N Venugopala. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Anroop B Nair's work in the field of antibacterial agents exemplifies the impact of innovation in healthcare. His contributions through numerous patents highlight the importance of research in combating microbial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…